Pharmacovigilance – News and Features

News
Nanogen Gains Access to Schizophrenia Markers
Nanogen acquires rights to genetic markers related to schizophrenia and responses to antipsychotic therapies from Diagnostics CRC and Queensland University of Technology

News
Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
Study suggests adult stem cells cultivated from patients' own blood can improve the patients’ life whose lower extremities are affected by peripheral vascular disease.

News
Turning Stem Cells Taken from fat Tissue into Cancer-Targeted Therapeutics
Researchers derive mesenchymal stem cells from human fat tissue and engineered them into suicide genes that destroy tumors.

News
BioWisdom Partners with Astrazeneca for Safety Intelligence Program
The Safety Intelligence Program applies technology and methodology to deliver an Intelligence System that will be used to support drug safety risk assessment at early stages of the drug discovery process.

News
Clinical Trial Suggests Bone Marrow Stem Cells are Useful for Spinal Cord Injury
PrimeCell has provided pre-clinical studies for a clinical trial to assess the efficacy of implanting autologous bone marrow stem cells into spinal cord injury patients.

News
FISH on a Chip Offers Better Cancer Diagnosis
University of Alberta researchers have miniaturized and automated a diagnostic test for cancer onto a microfluidic chip.

News
Vastox Announces Significant Progress in Pharmaceutical Services Business
VASTox will use its zebrafish technology platform to blind-screen selections of known compounds for safety and toxicity to validate to its clients how this technology can predict unwanted side effects.

News
Zora Biosciences Commercializes VTT's Biotechnology Expertise
Zora will provide laboratory services to pharmaceutical industry in the area of metabolomics and associated bioinformatics.

News
Inovio’s Selective Electrochemical Tumor Ablation Therapy Shows Significant Responses in Breast Cancer Study
Inovio’s Phase I/II study of patients with recurrent breast cancer showed safety, tolerability and achieved a 75% complete tumor response rate.

News
NCI Researchers Discover Genes that are Turned on at High Levels in Tumor-Associated Blood Vessels of Mice and Humans
The genes discovered are important potential targets for drugs that could selectively cut off a tumor's blood supply without affecting the blood vessels.
Advertisement